An insight into the synthesis and SAR of 2,4-thiazolidinediones (2,4-TZD) as multifunctional scaffold: A review.
2,4-Thiazolidinedione (2,4-TZD) is a versatile pharmacophore, a privileged scaffold, and a remarkable sulphur-containing heterocyclic compound with diverse pharmacological activities. The multifarious biological activities, due to different mechanisms of action, low cost, and easy availability of 2,4-TZD impressed medicinal chemists to integrate this moiety to develop various lead compounds with diverse therapeutic actions. This resulted in the swift development in the last decade for generating different new potential molecules bearing 2,4-TZD. In this review, the authors attempt to shape and present the latest investigations (2012 onwards) going on in generating promising 2,4-TZD containing lead compounds. The data has been collected and analyzed to develop the structure-activity relationship (SAR). The SAR and active pharmacophores of various leads accountable for antidiabetic, anticancer, antimicrobial, and antioxidant activities have also been illustrated. This review also highlighted some of the important chemical synthetic routes for the preparation of various 2,4-TZD derivatives. This review will definitely serve as a useful source of structural information to medicinal chemists and may be utilized for the strategic design of potent 2,4-TZD derivatives in the future.
Top-30
Journals
|
1
2
3
|
|
|
Journal of Heterocyclic Chemistry
3 publications, 7.5%
|
|
|
Archiv der Pharmazie
3 publications, 7.5%
|
|
|
Medicinal Chemistry
2 publications, 5%
|
|
|
Journal of Molecular Structure
2 publications, 5%
|
|
|
RSC Medicinal Chemistry
2 publications, 5%
|
|
|
Combinatorial Chemistry and High Throughput Screening
2 publications, 5%
|
|
|
Pharmaceuticals
1 publication, 2.5%
|
|
|
Anti-Cancer Agents in Medicinal Chemistry
1 publication, 2.5%
|
|
|
Current Organic Chemistry
1 publication, 2.5%
|
|
|
Future Medicinal Chemistry
1 publication, 2.5%
|
|
|
Bioorganic Chemistry
1 publication, 2.5%
|
|
|
Journal of Saudi Chemical Society
1 publication, 2.5%
|
|
|
Medicinal Research Reviews
1 publication, 2.5%
|
|
|
Chemistry and Biodiversity
1 publication, 2.5%
|
|
|
Letters in Drug Design and Discovery
1 publication, 2.5%
|
|
|
New Journal of Chemistry
1 publication, 2.5%
|
|
|
Phosphorus, Sulfur and Silicon and the Related Elements
1 publication, 2.5%
|
|
|
Advances in Heterocyclic Chemistry
1 publication, 2.5%
|
|
|
Chemical Biology and Drug Design
1 publication, 2.5%
|
|
|
ChemistryOpen
1 publication, 2.5%
|
|
|
RSC Advances
1 publication, 2.5%
|
|
|
Molecules
1 publication, 2.5%
|
|
|
ChemistrySelect
1 publication, 2.5%
|
|
|
Bioorganic and Medicinal Chemistry
1 publication, 2.5%
|
|
|
Scientific Reports
1 publication, 2.5%
|
|
|
European Journal of Medicinal Chemistry
1 publication, 2.5%
|
|
|
Journal of the Iranian Chemical Society
1 publication, 2.5%
|
|
|
BioChem
1 publication, 2.5%
|
|
|
Photochemical and Photobiological Sciences
1 publication, 2.5%
|
|
|
1
2
3
|
Publishers
|
2
4
6
8
10
12
|
|
|
Wiley
11 publications, 27.5%
|
|
|
Bentham Science Publishers Ltd.
8 publications, 20%
|
|
|
Elsevier
6 publications, 15%
|
|
|
Royal Society of Chemistry (RSC)
4 publications, 10%
|
|
|
Springer Nature
4 publications, 10%
|
|
|
MDPI
3 publications, 7.5%
|
|
|
Taylor & Francis
2 publications, 5%
|
|
|
King Saud University
1 publication, 2.5%
|
|
|
2
4
6
8
10
12
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.